News

N2OFF Acquires MitoCareX: A New Frontier in Cancer Treatment

N2OFF Acquires MitoCareX: A New Frontier in Cancer Treatment

N2OFF Acquires MitoCareX Bio, Innovating Cancer Treatment

Neve Yarak, Israel - N2OFF, Inc. (NASDAQ: NITO), a forward-thinking clean tech company, has embarked on an exciting journey by signing a definitive agreement to acquire MitoCareX Bio Ltd. MitoCareX is a cutting-edge biotech company that focuses on drug discovery aimed at developing innovative therapeutics for cancers considered hard to treat.

Details of the Acquisition

The acquisition involves a securities purchase and exchange agreement where N2OFF will fully take over MitoCareX. N2OFF plans to purchase shares from the current owners, including SciSparc Ltd. (NASDAQ: SPRC), Dr. Alon Silberman, and Professor Ciro Leonardo Pierri. As part of the deal, N2OFF will pay $700,000 for 4,961 shares and will exchange a significant number of additional shares, culminating in an ownership stake that represents 40% of MitoCareX’s fully diluted equity.

Moreover, the Sellers will enjoy a fractional entitlement to 30% of N2OFF’s financing proceeds, capped at $1.6 million, for the next five years. This development marks MitoCareX’s transformation into a wholly owned subsidiary of N2OFF, complete with a new board established by N2OFF. This move is subject to the approval of N2OFF’s stockholders.

Commitment to Support

The agreement also includes a pledge by N2OFF to support MitoCareX financially in the initial years post-acquisition. This will consist of an initial cash injection of $1,000,000 to ensure MitoCareX can efficiently operate and expand its research and development activities.

MitoCareX's Mission in Oncology

MitoCareX is dedicated to tackling the challenging field of oncology, particularly in developing therapies that target the mitochondrial SLC25 protein family. By employing sophisticated 3D comparative modeling techniques, MitoCareX aims to discover small molecule therapeutics that can combat various cancer types effectively. Their advanced in vitro screening processes further validate the potential of these molecules as effective cancer treatments.

The global market for cancer therapeutics and biotherapeutics is booming, with projections suggesting it could surge from a valuation of approximately $194.1 billion to $344.1 billion within the coming years. MitoCareX is well-positioned to capitalize on this growth and provide crucial advancements in cancer treatment.

Enhancing Drug Discovery

By merging computational chemistry, structural biology, and precision medicine, MitoCareX can expedite the process of discovering groundbreaking oncology treatments. This unique blend of methodologies enables them to identify novel therapeutic targets and accelerate the development of drugs that could potentially change the landscape of cancer treatment.

Strategic Collaborations within N2OFF

Mr. Amitay Weiss, who is the Chairman of N2OFF's Board of Directors, also holds a similar position at SciSparc, establishing a strategic connection between the two companies. Additionally, Ms. Liat Sidi from N2OFF’s Board of Directors is a member of SciSparc’s Board, facilitating streamlined collaboration and knowledge sharing.

About N2OFF, Inc.

N2OFF, Inc., which has evolved from its previous identity as Save Foods, Inc., is committed to delivering sustainable solutions across clean technology and agri-tech sectors. With a focus on reducing greenhouse gas emissions and enhancing agricultural practices, N2OFF aims to promote eco-friendly and economically viable solutions.

Recently, N2OFF entered the solar photovoltaic market, backing a significant project by Solterra Renewable Energy Ltd. focused on a capacity of 111 MWp. The company is also committed to leveraging innovations in agriculture combat pathogens during post-harvest treatments for fruits and vegetables.

Frequently Asked Questions

What is N2OFF's latest acquisition?

N2OFF has acquired MitoCareX Bio Ltd., a biotech firm specializing in drug discovery for hard-to-treat cancers.

How will MitoCareX enhance N2OFF's offerings?

MitoCareX brings innovative drug discovery capabilities that align with N2OFF's mission of sustainability and health advancements.

What are MitoCareX's primary research focuses?

MitoCareX is focused on developing therapies targeting the mitochondrial SLC25 protein family to treat challenging cancers.

How is N2OFF supporting MitoCareX financially?

N2OFF has pledged an initial cash investment of $1,000,000 to support MitoCareX's operations post-acquisition.

What are the expected market trends for cancer therapeutics?

The cancer therapeutics market is projected to grow significantly, from an estimated $194.1B to approximately $344.1B by 2031.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 154

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 197

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 101

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 227

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 16

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 127

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 124

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 130

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 112

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading

Top 5 Most Recently Viewed Articles

Pyramid Global Hospitality Welcomes Anthony Torres Amid Award Success

Updated Category News Views 281

Pyramid Global Hospitality Welcomes a New Leader The renowned hospitality management company, Pyramid Global Hospitality, has recently appointed Anthony Torres as its vice president of food and beverage. In this pivotal role, he will oversee the culinary vision that has underpinned the company’s award-winning reputation in the hospitality industry. Celebrating Culinary...

Continue Reading
Shamari Reid's Audiobook Earns Audie Award Nomination

Updated Category News Views 117

Shamari Reid's Audiobook Earns Audie Award Nomination Heinemann, a respected name in educational publishing, has announced that Shamari Reid's audiobook, Humans Who Teach: A Guide for Centering Love, Justice, and Liberation in Schools, has been nominated for the prestigious Audie Award in the business and personal development category. This recognition highlights the...

Continue Reading
Azazie's Summer RSVP Collection: Versatility Unleashed

Updated Category News Views 19

The Shift from Singular to Seasonal Dressing You ever get that feeling when you’re dressing for a season full of events, rather than pinning everything on just one big day? That’s what Azazie’s latest move is about, tearing up those old pages of the calendar marked just for weddings and making room for the whole shebang—every lunch, night out, and festive fling...

Continue Reading
Growing Demand for Automated Boarding Gates: Market Trends

Updated Category News Views 197

Overview of the Automatic Boarding Gates Market The automatic boarding gates market is on the rise, with expectations to reach $132.8 million by the end of the forecast period in 2032. Key factors driving this growth include an increase in air passenger traffic, ongoing technological advancements, and heightened security needs in the industry. A recent report shows that...

Continue Reading
Stride, Inc.'s Compliance Issues Under Investigation by SEC

Updated Category News Views 330

Stride, Inc. Faces Serious Investor Scrutiny Shares of Stride, Inc. (NYSE: LRN), a notable player in the educational technology sector, have seen a sharp decline in value due to recent allegations made against the company. The complaints, originating from a New Mexico school district, allege serious infractions, including fraudulent practices and conflicts of interest,...

Continue Reading